Pancreatic Cancer, Research and Clinical Trials

Meet the investigator: Michael B. Wallace, M.D.

By Nicole Ferrara • March 11, 2020
Estimated reading time: 1 minute

At Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Michael B. Wallace, M.D., a gastroenterologist at Mayo Clinic in Jacksonville, Florida, discusses his research on the early detection of pancreatic cancer.

Related

This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.

cancer pancreatic cancer Pancreatic Cancer research Research and Clinical Trials
Subscribe
Request an Appointment
Find a Clinical Trial
Detecting pancreatic cancer through changes in body composition and metabolism

New Mayo Clinic research represents a promising step toward identifying biological signals or biomarkers that may aid in early detection.

Teamwork and a new nickname inspire patient through pancreatic cancer treatment

After a pancreatic cancer diagnosis and multiple cardiac arrests during treatment, "Tiger" Dick Whetstone finds help and hope at Mayo Clinic.

Beyond weight loss: Bariatric surgery may reduce cancer risk

Dr. Maria Linnaus discusses the link between obesity and cancer risk and how bariatric surgery may reduce that risk.